Posts

Illuminating the Unknown: How Fluorescent Caves May Off...

Deep within the subterranean realm of South Dakota’s Wind Cave, a breathtaking t...

Pilot Study Reveals Chewing Gum Releases Microplastics ...

Plastic pollution has become an omnipresent concern within modern society, perme...

China conditionally approves Hutchmed’s Tazverik for fo...

NMPA has granted conditional approval for Hutchmed’s Tazverik to treat adults wi...

Global funding cuts reversing decades of tuberculosis p...

Ahead of World Tuberculosis Day on 24 March, the WHO has said that global fundin...

How to manage regulatory complexities with clinical tri...

Clinical trials must use effective electronic data capture platforms that priori...

Menarini to enhance BPDCN detection with VisualDx’s link

Menarini Group has announced a partnership with VisualDx to enhance the diagnosi...

Funding drought: how can biotech and biopharma keep tri...

Biotech and biopharma companies have battled with a drought of private investmen...

New Device Facilitates Direct Communication Between Mul...

Quantum computing stands on the precipice of revolutionizing the way we approach...

Almost 50% of Depression Cases May Be Resistant to Trea...

In a recent groundbreaking study, researchers have unveiled alarming statistics ...

Deadly Bacteria Evolve Antimicrobial Production, Elimin...

A groundbreaking study led by the University of Pittsburgh School of Medicine ha...

Opko & Entera Enter Partnership to Develop Obesity Pill

Opko Health and Entera Bio have formally announced their collaboration as the bi...

Taiho spends $400 million with a Swiss partner to “turb...

Taiho Pharmaceutical has paid Otsuka $400 million in upfront purchase of the Ara...

Sarepta’s Elevidys Under Scrutiny Following Fatal Liver...

A young patient diagnosed with Duchenne muscular dystrophy has passed away follo...

Pfizer sells 7.3% stake in Haleon for $3.3bn

Pfizer has divested its residual shareholding in Haleon, representing 7.3% of th...

Oxford BioTherapeutics and Roche link on antibody cance...

OBT has entered a multi-year partnership with Roche to discover antibody-based t...